Thoralf Christoffersen

Interleukin-6 and C-reactive protein as prognostic biomarkers in metastatic colorectal cancer

H. Sorbye, E. Kure, T. Guren, 2016 .

Interleukin-6 and C-reactive protein as prognostic biomarkers in metastatic colorectal cancer

H. Sorbye, E. Kure, T. Guren, 2016 .

Randomized phase III study of 5-fluorouracil/folinate/oxaliplatin given continuously or intermittently with or without cetuximab, as first-line treatment of metastatic colorectal cancer: The NORDIC VII study (NCT00145314), by the Nordic Colorectal Cancer Biomodulation Group.

H. Sorbye, E. Kure, E. Skovlund, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Differential effects of epidermal growth factor (EGF) receptor ligands on receptor binding, downstream signalling pathways and DNA synthesis in hepatocytes

J. Ødegård, G. H. Thoresen, T. Christoffersen, 2017, Growth factors.